Alle verbonden artikelen

Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986.

Auteurs : De Santis M, Bellmunt J, Mead G, Kerst JM, Leahy M, Maroto P, Gil T, Marreaud S, Daugaard G, Skoneczna I, Collette S, Lorent J, de Wit R, Sylvester R
Jaar : 2012
Journal : J. Clin. Oncol.
Volume : 30(2)
Pagina's : 191-9

Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.

Auteurs : Najar M, Raicevic G, Jebbawi F, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L
Jaar : 2012
Journal : Immunol. Lett.
Volume : 146(1-2)
Pagina's : 50-6

Le souhait d’aide psychologique des patients âgés atteints d’un cancer.

Auteurs : Libert Y, Merckaert I, Dubruille S, Razavi D
Jaar : 2012
Journal : Psychooncology
Volume : 6
Pagina's : 29-32

Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming.

Auteurs : Najar M, Raicevic G, Kazan HF, De Bruyn C, Bron D, Toungouz M, Lagneaux L
Jaar : 2012
Journal : Stem Cell Rev
Volume : 8(4)
Pagina's : 1188-98

Role and interpretation of FDG-PET/CT in HIV patients with fever of unknown origin: a prospective study.

Auteurs : Martin C, Castaigne C, Tondeur M, Flamen P, De Wit S
Jaar : 2012
Journal : J Int AIDS Soc
Volume : 15(4)
Pagina's : 18107

Decision-making in oncology: a selected literature review and some recommendations for the future.

Auteurs : Ménard C, Merckaert I, Razavi D, Libert Y
Jaar : 2012
Journal : Curr Opin Oncol
Volume : 24(4)
Pagina's : 381-90

Assessment of the intrinsic pluripotency of mesoderm-derived stem cells from different niches.

Auteurs : De Kock J, Najar M, Bolleyn J, Al Battah F, Raicevic G, Govaere O, Branson S, Meganathan K, Gaspar JA, Roskams T, Sachinidis A, Lagneaux L, Vanhaecke T, Rogiers V
Jaar : 2012
Journal : ALTEX
Volume : 29
Pagina's : 31-9

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Wo

Auteurs : Berghmans T, Lafitte JJ, Giner V, Berchier MC, Scherpereel A, Lewin D, Paesmans M, Meert AP, Bosschaerts T, Leclercq N, Sculier JP
Jaar : 2012
Journal : Lung Cancer
Volume : 77(3)
Pagina's : 605-610

Clinical trial design in head and neck cancer: from past experiences to future perspectives.

Auteurs : de Castro G Jr, Henrique dos Anjos C, Lalami Y, Awada A
Jaar : 2012
Journal : Clinical Investigation
Volume : 2(5)
Pagina's : 473-481

A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints.

Auteurs : Fumagalli D, Bedard PL, Nahleh Z, Michiels S, Sotiriou C, Loi S, Sparano JA, Ellis M, Hylton N, Zujewski JA, Hudis C, Esserman L, Piccart-Gebhart M
Jaar : 2012
Journal : Lancet Oncol
Volume : 13(6)
Pagina's : e240-8

Euthanasia: from ethical debate to clinical reality.

Auteurs : Berghmans T, Lossignol D
Jaar : 2012
Journal : Eur. Respir. J.
Volume : 40(4)
Pagina's : 804-5

Communication skills training for residents : which variables predict learning of skills?

Auteurs : Bragard I, Merckaert I, Libert Y, Delvaux N, Etienne AM, Marchal S, Reynaert C, Razavi D
Jaar : 2012
Journal : Open Journal of Medical Psychology
Volume : 1
Pagina's : 68-75

Liquid biopsy to test new treatment strategies in breast cancer: are we there yet?

Auteurs : Ignatiadis M, Piccart-Gebhart M
Jaar : 2012
Journal : Ann Oncol
Volume : 23(7)
Pagina's : 1653-5

Technological innovation and healthcare professionals' workloads: an ambiguous relationship.

Auteurs : de Pires DE, Bertoncini JH, Trindade Lde L, Matos E, de Azambuja E, Borges AM
Jaar : 2012
Journal : Rev Gaucha Enferm
Volume : 33(1)
Pagina's : 157-68

Anaplastic lymphoma kinase (ALK) inhibitors for second-line therapy of non-small cell lung cancer.

Auteurs : Berghmans T, Remmelink M, Awada A
Jaar : 2012
Journal : Lung Cancer : Targets and Therapy
Volume : 3
Pagina's : 91-99

Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial design.

Auteurs : Eiermann W, Bergh J, Cardoso F, Conte P, Crown J, Curtin NJ, Gligorov J, Gusterson B, Joensuu H, Linderholm BK, Martin M, Penault-Llorca F, Pestalozzi BC, Razis E, Sotiriou C, Tjulandin S, Viale G
Jaar : 2012
Journal : Breast
Volume : 21(1)
Pagina's : 20-6

Pemetrexed salvage chemotherapy for NSCLC: implementation study].

Auteurs : Jungels C, Berghmans T, Meert AP, Lafitte JJ, Scherpereel A, Sculier JP
Jaar : 2012
Journal : Rev Mal Respir
Volume : 29(1)
Pagina's : 21-7

A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer.

Auteurs : Bleiberg H, Vandebroek A, Deleu I, Vergauwe P, Rezaei Kalantari H, DHaens G, Paesmans M, Peeters M, Efira A, Humblet Y
Jaar : 2012
Journal : Acta Gastroenterol Belg
Volume : 75(1)
Pagina's : 14-21

Oncological intensive care: 2011 year's review].

Auteurs : Sculier JP, Berghmans T, Meert AP
Jaar : 2012
Journal : Rev Med Brux
Volume : 33(6)
Pagina's : 540-4

Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumours.

Auteurs : Awada A, Hendlisz A, Christensen O, Lathia CD, Bartholomeus S, Lebrun F, de Valeriola D, Brendel E, Radtke M, Delaunoit T, Piccart-Gebhart M, Gil T
Jaar : 2012
Journal : Eur. J. Cancer
Volume : 48(4)
Pagina's : 465-74